 Jeanelle Sheeder
Concepts (612)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraception | 18 | 2023 | 118 | 7.690 |
Why?
| | Contraceptive Agents, Female | 23 | 2023 | 65 | 4.240 |
Why?
| | Family Planning Services | 11 | 2022 | 68 | 3.740 |
Why?
| | Contraceptive Agents | 7 | 2023 | 57 | 3.530 |
Why?
| | Contraception Behavior | 18 | 2023 | 81 | 3.490 |
Why?
| | Pregnancy in Adolescence | 17 | 2015 | 77 | 3.370 |
Why?
| | Desogestrel | 19 | 2023 | 41 | 2.860 |
Why?
| | Pregnancy | 73 | 2023 | 5694 | 2.430 |
Why?
| | Long-Acting Reversible Contraception | 8 | 2023 | 25 | 2.400 |
Why?
| | Abortion, Induced | 12 | 2023 | 73 | 2.120 |
Why?
| | Prenatal Care | 9 | 2020 | 252 | 2.110 |
Why?
| | Hospitals, Religious | 5 | 2020 | 5 | 1.850 |
Why?
| | Counseling | 6 | 2020 | 353 | 1.730 |
Why?
| | Intrauterine Devices | 7 | 2019 | 24 | 1.670 |
Why?
| | Drug Implants | 17 | 2023 | 72 | 1.660 |
Why?
| | Female | 158 | 2023 | 61588 | 1.610 |
Why?
| | Gynecology | 10 | 2023 | 184 | 1.540 |
Why?
| | Adolescent Behavior | 9 | 2015 | 482 | 1.530 |
Why?
| | Postpartum Period | 10 | 2022 | 271 | 1.530 |
Why?
| | Adolescent | 82 | 2023 | 18483 | 1.470 |
Why?
| | Young Adult | 60 | 2023 | 10799 | 1.430 |
Why?
| | Pregnancy Outcome | 8 | 2021 | 349 | 1.300 |
Why?
| | Reproductive Health | 4 | 2023 | 68 | 1.290 |
Why?
| | Endometrial Neoplasms | 10 | 2022 | 144 | 1.280 |
Why?
| | Catholicism | 5 | 2020 | 9 | 1.220 |
Why?
| | Humans | 174 | 2023 | 119032 | 1.160 |
Why?
| | Colorado | 33 | 2023 | 4196 | 1.100 |
Why?
| | Obstetrics | 7 | 2023 | 162 | 1.080 |
Why?
| | Contraceptives, Oral, Combined | 2 | 2023 | 16 | 1.060 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 687 | 1.030 |
Why?
| | Postnatal Care | 3 | 2021 | 68 | 1.000 |
Why?
| | Adult | 85 | 2023 | 31525 | 0.990 |
Why?
| | Health Knowledge, Attitudes, Practice | 10 | 2020 | 1185 | 0.980 |
Why?
| | Sexual Behavior | 7 | 2022 | 437 | 0.920 |
Why?
| | Enoxaparin | 2 | 2020 | 51 | 0.910 |
Why?
| | Patient Satisfaction | 5 | 2023 | 610 | 0.900 |
Why?
| | Pyridones | 2 | 2020 | 119 | 0.870 |
Why?
| | Adolescent Health Services | 3 | 2020 | 67 | 0.860 |
Why?
| | Religion and Medicine | 3 | 2020 | 28 | 0.850 |
Why?
| | Cross-Sectional Studies | 21 | 2023 | 4552 | 0.810 |
Why?
| | Levonorgestrel | 4 | 2018 | 32 | 0.770 |
Why?
| | Pyrazoles | 2 | 2020 | 363 | 0.750 |
Why?
| | Pregnant Women | 2 | 2019 | 132 | 0.740 |
Why?
| | Parity | 5 | 2016 | 101 | 0.740 |
Why?
| | Mothers | 5 | 2022 | 683 | 0.740 |
Why?
| | Venous Thromboembolism | 2 | 2020 | 234 | 0.730 |
Why?
| | Group Processes | 2 | 2018 | 56 | 0.730 |
Why?
| | Religion and Psychology | 1 | 2019 | 26 | 0.720 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 79 | 0.720 |
Why?
| | Hysterectomy | 6 | 2019 | 117 | 0.710 |
Why?
| | Ovarian Neoplasms | 6 | 2020 | 420 | 0.690 |
Why?
| | Surveys and Questionnaires | 22 | 2023 | 4709 | 0.690 |
Why?
| | Pregnancy Rate | 2 | 2017 | 55 | 0.690 |
Why?
| | Sex Offenses | 1 | 2022 | 148 | 0.680 |
Why?
| | Rural Health Services | 1 | 2019 | 93 | 0.680 |
Why?
| | Patient-Centered Care | 2 | 2021 | 497 | 0.670 |
Why?
| | Vulnerable Populations | 1 | 2020 | 147 | 0.660 |
Why?
| | Financial Support | 1 | 2018 | 21 | 0.650 |
Why?
| | Intrauterine Devices, Copper | 5 | 2018 | 8 | 0.650 |
Why?
| | Health Care Sector | 1 | 2018 | 26 | 0.650 |
Why?
| | Pregnancy, Unplanned | 3 | 2017 | 32 | 0.640 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 237 | 0.630 |
Why?
| | Community Health Services | 1 | 2019 | 212 | 0.620 |
Why?
| | Prosthesis Implantation | 2 | 2017 | 141 | 0.620 |
Why?
| | Health Services Accessibility | 3 | 2022 | 781 | 0.600 |
Why?
| | Luteal Phase | 1 | 2017 | 44 | 0.590 |
Why?
| | Intrauterine Devices, Medicated | 6 | 2017 | 25 | 0.580 |
Why?
| | Infant, Low Birth Weight | 2 | 2015 | 125 | 0.580 |
Why?
| | Retrospective Studies | 32 | 2023 | 12990 | 0.570 |
Why?
| | Parenting | 1 | 2020 | 252 | 0.570 |
Why?
| | Delivery of Health Care | 2 | 2023 | 869 | 0.570 |
Why?
| | Lacerations | 3 | 2022 | 30 | 0.560 |
Why?
| | Interprofessional Relations | 1 | 2018 | 262 | 0.550 |
Why?
| | Ambulatory Care Facilities | 4 | 2019 | 219 | 0.540 |
Why?
| | Depression, Postpartum | 3 | 2020 | 99 | 0.540 |
Why?
| | Genital Neoplasms, Female | 4 | 2020 | 72 | 0.530 |
Why?
| | Group Structure | 1 | 2015 | 1 | 0.530 |
Why?
| | Health Personnel | 1 | 2021 | 588 | 0.530 |
Why?
| | Guatemala | 3 | 2021 | 296 | 0.520 |
Why?
| | Perimenopause | 1 | 2015 | 59 | 0.520 |
Why?
| | Carcinoma, Endometrioid | 3 | 2022 | 47 | 0.510 |
Why?
| | Risk | 2 | 2017 | 854 | 0.510 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2019 | 1244 | 0.500 |
Why?
| | Multicenter Studies as Topic | 1 | 2015 | 253 | 0.500 |
Why?
| | Fertility Preservation | 3 | 2023 | 47 | 0.500 |
Why?
| | Uterus | 1 | 2015 | 197 | 0.490 |
Why?
| | Patient Selection | 3 | 2015 | 675 | 0.480 |
Why?
| | Safety-net Providers | 1 | 2015 | 96 | 0.480 |
Why?
| | Intention | 4 | 2018 | 142 | 0.480 |
Why?
| | Maternal Age | 3 | 2018 | 122 | 0.470 |
Why?
| | Middle Aged | 39 | 2022 | 27627 | 0.460 |
Why?
| | Primary Health Care | 4 | 2023 | 1560 | 0.450 |
Why?
| | Goals | 1 | 2014 | 167 | 0.440 |
Why?
| | Attitude to Health | 3 | 2020 | 410 | 0.430 |
Why?
| | Estradiol | 1 | 2015 | 476 | 0.430 |
Why?
| | Choice Behavior | 3 | 2019 | 160 | 0.430 |
Why?
| | Papillomavirus Vaccines | 1 | 2015 | 221 | 0.430 |
Why?
| | Uterine Cervical Neoplasms | 3 | 2021 | 216 | 0.430 |
Why?
| | Internship and Residency | 6 | 2023 | 1006 | 0.420 |
Why?
| | Postoperative Complications | 9 | 2020 | 2235 | 0.410 |
Why?
| | Premature Birth | 1 | 2015 | 284 | 0.410 |
Why?
| | Obstetric Labor Complications | 2 | 2022 | 32 | 0.390 |
Why?
| | Feasibility Studies | 7 | 2022 | 749 | 0.390 |
Why?
| | Mass Screening | 7 | 2023 | 1052 | 0.390 |
Why?
| | Magnetoencephalography | 13 | 2000 | 103 | 0.380 |
Why?
| | United States | 19 | 2021 | 12557 | 0.380 |
Why?
| | Disclosure | 2 | 2022 | 102 | 0.360 |
Why?
| | Functional Laterality | 11 | 2001 | 208 | 0.360 |
Why?
| | Robotic Surgical Procedures | 3 | 2016 | 89 | 0.360 |
Why?
| | Nurse Midwives | 2 | 2020 | 21 | 0.360 |
Why?
| | Socioeconomic Factors | 5 | 2021 | 1129 | 0.360 |
Why?
| | Health Behavior | 1 | 2015 | 720 | 0.350 |
Why?
| | Lymph Nodes | 3 | 2018 | 455 | 0.350 |
Why?
| | Birth Intervals | 2 | 2019 | 16 | 0.340 |
Why?
| | Chlamydia trachomatis | 2 | 2007 | 36 | 0.340 |
Why?
| | Communication | 3 | 2022 | 761 | 0.340 |
Why?
| | Condoms | 3 | 2017 | 110 | 0.340 |
Why?
| | Evoked Potentials, Auditory | 10 | 2001 | 201 | 0.340 |
Why?
| | Life Style | 3 | 2021 | 431 | 0.340 |
Why?
| | Intrauterine Device Expulsion | 3 | 2017 | 7 | 0.320 |
Why?
| | Infant, Small for Gestational Age | 2 | 2019 | 73 | 0.320 |
Why?
| | Chlamydia Infections | 2 | 2007 | 65 | 0.320 |
Why?
| | Patient Participation | 1 | 2012 | 369 | 0.320 |
Why?
| | Women's Health | 2 | 2020 | 274 | 0.310 |
Why?
| | Attitude | 3 | 2019 | 231 | 0.300 |
Why?
| | Cohort Studies | 11 | 2021 | 5117 | 0.300 |
Why?
| | Pregnancy Complications | 4 | 2019 | 448 | 0.300 |
Why?
| | Vaccination | 1 | 2015 | 1223 | 0.300 |
Why?
| | Male | 43 | 2022 | 57818 | 0.290 |
Why?
| | Uterine Cervicitis | 1 | 2006 | 6 | 0.290 |
Why?
| | Time Factors | 11 | 2019 | 6414 | 0.290 |
Why?
| | Organizational Policy | 2 | 2019 | 70 | 0.290 |
Why?
| | Marijuana Use | 2 | 2019 | 157 | 0.280 |
Why?
| | Prospective Studies | 14 | 2022 | 6477 | 0.270 |
Why?
| | Age Factors | 8 | 2016 | 2995 | 0.270 |
Why?
| | Aged, 80 and over | 11 | 2021 | 6562 | 0.270 |
Why?
| | Aged | 18 | 2021 | 19661 | 0.270 |
Why?
| | Depression | 4 | 2023 | 1137 | 0.270 |
Why?
| | Perineum | 3 | 2022 | 29 | 0.270 |
Why?
| | Gelatin | 2 | 2016 | 36 | 0.260 |
Why?
| | Pregnancy Trimester, First | 4 | 2023 | 126 | 0.260 |
Why?
| | Clinical Competence | 3 | 2018 | 951 | 0.260 |
Why?
| | Fetal Death | 2 | 2016 | 53 | 0.260 |
Why?
| | Electronics, Medical | 1 | 2004 | 13 | 0.250 |
Why?
| | Weight Gain | 6 | 2021 | 493 | 0.250 |
Why?
| | Laparotomy | 2 | 2015 | 106 | 0.250 |
Why?
| | Thrombin | 2 | 2016 | 143 | 0.250 |
Why?
| | Database Management Systems | 1 | 2004 | 56 | 0.250 |
Why?
| | Telemedicine | 2 | 2023 | 668 | 0.240 |
Why?
| | Pregnancy Trimester, Second | 4 | 2018 | 70 | 0.240 |
Why?
| | Aromatherapy | 1 | 2023 | 2 | 0.240 |
Why?
| | Fellowships and Scholarships | 2 | 2018 | 250 | 0.240 |
Why?
| | Social Support | 2 | 2020 | 542 | 0.240 |
Why?
| | Contraceptive Devices | 1 | 2023 | 1 | 0.230 |
Why?
| | Child | 14 | 2023 | 19137 | 0.230 |
Why?
| | Pain, Procedural | 1 | 2023 | 12 | 0.230 |
Why?
| | Birth Weight | 1 | 2006 | 465 | 0.230 |
Why?
| | Ethinyl Estradiol | 1 | 2023 | 17 | 0.230 |
Why?
| | Cost-Benefit Analysis | 3 | 2020 | 554 | 0.230 |
Why?
| | Decision Making | 4 | 2016 | 809 | 0.230 |
Why?
| | Patient Health Questionnaire | 1 | 2023 | 19 | 0.230 |
Why?
| | Fertility | 3 | 2023 | 135 | 0.230 |
Why?
| | House Calls | 2 | 2019 | 133 | 0.220 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 94 | 0.220 |
Why?
| | Leuprolide | 1 | 2022 | 20 | 0.220 |
Why?
| | Semen | 1 | 2022 | 18 | 0.220 |
Why?
| | Patient Preference | 2 | 2015 | 170 | 0.220 |
Why?
| | Pain | 2 | 2018 | 736 | 0.220 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 993 | 0.220 |
Why?
| | Pregnancy Tests | 2 | 2017 | 7 | 0.210 |
Why?
| | Gestational Age | 4 | 2021 | 765 | 0.210 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2021 | 38 | 0.200 |
Why?
| | Chorioamnionitis | 1 | 2021 | 37 | 0.200 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 20 | 0.200 |
Why?
| | Decision Support Techniques | 2 | 2020 | 364 | 0.200 |
Why?
| | Students, Medical | 2 | 2016 | 311 | 0.200 |
Why?
| | Self Report | 3 | 2021 | 699 | 0.200 |
Why?
| | beta Catenin | 2 | 2022 | 219 | 0.190 |
Why?
| | Maternal-Child Health Services | 1 | 2020 | 9 | 0.190 |
Why?
| | Lymph Node Excision | 3 | 2018 | 158 | 0.190 |
Why?
| | Parturition | 2 | 2019 | 53 | 0.190 |
Why?
| | Accelerometry | 1 | 2021 | 72 | 0.190 |
Why?
| | Evoked Potentials, Somatosensory | 2 | 1999 | 33 | 0.190 |
Why?
| | Outpatients | 3 | 2023 | 325 | 0.190 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 103 | 0.180 |
Why?
| | Magnetics | 2 | 1999 | 38 | 0.180 |
Why?
| | Patient Education as Topic | 3 | 2019 | 699 | 0.180 |
Why?
| | Health Facilities | 1 | 2020 | 75 | 0.180 |
Why?
| | Pharmacogenetics | 1 | 2021 | 151 | 0.180 |
Why?
| | Home Health Nursing | 1 | 2019 | 9 | 0.180 |
Why?
| | Uterine Hemorrhage | 2 | 2021 | 36 | 0.180 |
Why?
| | Transgender Persons | 1 | 2022 | 135 | 0.180 |
Why?
| | Menstruation Disturbances | 1 | 2019 | 12 | 0.180 |
Why?
| | Medical Oncology | 2 | 2019 | 229 | 0.180 |
Why?
| | Factor Analysis, Statistical | 1 | 2020 | 270 | 0.180 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 50 | 0.180 |
Why?
| | Hysterectomy, Vaginal | 1 | 2019 | 7 | 0.180 |
Why?
| | Double-Blind Method | 5 | 2018 | 1687 | 0.180 |
Why?
| | Cues | 1 | 2022 | 298 | 0.180 |
Why?
| | Cytochrome P450 Family 3 | 1 | 2019 | 2 | 0.180 |
Why?
| | Neoplasm Staging | 6 | 2020 | 1223 | 0.170 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2019 | 5 | 0.170 |
Why?
| | Vaginosis, Bacterial | 1 | 2019 | 13 | 0.170 |
Why?
| | Cancer Pain | 1 | 2019 | 20 | 0.170 |
Why?
| | Insulin Resistance | 2 | 2008 | 1184 | 0.170 |
Why?
| | Treatment Outcome | 10 | 2020 | 9346 | 0.170 |
Why?
| | Obesity | 5 | 2016 | 2751 | 0.170 |
Why?
| | Live Birth | 1 | 2019 | 47 | 0.170 |
Why?
| | Clothing | 1 | 2019 | 22 | 0.170 |
Why?
| | Databases, Factual | 3 | 2021 | 1231 | 0.170 |
Why?
| | Hygiene | 1 | 2019 | 32 | 0.170 |
Why?
| | Anesthesia, Inhalation | 1 | 2018 | 6 | 0.170 |
Why?
| | Nitrous Oxide | 1 | 2018 | 12 | 0.170 |
Why?
| | Anesthetics, Inhalation | 1 | 2018 | 14 | 0.170 |
Why?
| | Anesthesia, Intravenous | 1 | 2018 | 12 | 0.170 |
Why?
| | Physician Assistants | 1 | 2020 | 68 | 0.170 |
Why?
| | Anesthetics, Intravenous | 1 | 2018 | 34 | 0.170 |
Why?
| | Organ Transplantation | 1 | 2021 | 165 | 0.170 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1390 | 0.170 |
Why?
| | Nurse Practitioners | 1 | 2020 | 107 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2019 | 94 | 0.160 |
Why?
| | Genitalia, Female | 1 | 2018 | 40 | 0.160 |
Why?
| | Pilot Projects | 3 | 2021 | 1420 | 0.160 |
Why?
| | Ovariectomy | 2 | 2015 | 124 | 0.160 |
Why?
| | Databases as Topic | 2 | 2008 | 73 | 0.160 |
Why?
| | Hemostasis, Surgical | 2 | 2016 | 22 | 0.160 |
Why?
| | Adenocarcinoma | 2 | 2015 | 812 | 0.160 |
Why?
| | Progesterone | 1 | 2019 | 242 | 0.160 |
Why?
| | Oncologists | 1 | 2018 | 31 | 0.160 |
Why?
| | Psychometrics | 4 | 2009 | 631 | 0.160 |
Why?
| | Commerce | 1 | 2018 | 56 | 0.160 |
Why?
| | Off-Label Use | 1 | 2018 | 48 | 0.160 |
Why?
| | Risk-Taking | 2 | 2019 | 319 | 0.160 |
Why?
| | Culture | 1 | 2019 | 129 | 0.160 |
Why?
| | Sterilization, Reproductive | 1 | 2017 | 4 | 0.150 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 102 | 0.150 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 136 | 0.150 |
Why?
| | Hysteroscopy | 1 | 2017 | 7 | 0.150 |
Why?
| | Body Mass Index | 4 | 2019 | 2092 | 0.150 |
Why?
| | Infant, Newborn | 6 | 2021 | 5256 | 0.150 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 79 | 0.150 |
Why?
| | Quality of Health Care | 2 | 2021 | 586 | 0.150 |
Why?
| | Delivery, Obstetric | 4 | 2022 | 125 | 0.150 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2018 | 59 | 0.150 |
Why?
| | Family | 1 | 2021 | 587 | 0.150 |
Why?
| | Bipolar Disorder | 1 | 1999 | 209 | 0.150 |
Why?
| | Surgeons | 2 | 2018 | 243 | 0.150 |
Why?
| | Salpingectomy | 2 | 2015 | 13 | 0.150 |
Why?
| | Incidence | 5 | 2019 | 2424 | 0.150 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2017 | 31 | 0.150 |
Why?
| | Professional-Patient Relations | 1 | 2018 | 147 | 0.150 |
Why?
| | Abortion, Therapeutic | 1 | 2016 | 5 | 0.140 |
Why?
| | Dilatation and Curettage | 1 | 2016 | 10 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2020 | 482 | 0.140 |
Why?
| | Follow-Up Studies | 8 | 2019 | 4596 | 0.140 |
Why?
| | Infant | 3 | 2023 | 8295 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 7 | 2001 | 3175 | 0.140 |
Why?
| | Minority Groups | 1 | 2018 | 237 | 0.140 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.140 |
Why?
| | Surgical Wound Infection | 1 | 2019 | 251 | 0.140 |
Why?
| | Conflict of Interest | 1 | 2018 | 120 | 0.140 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 93 | 0.140 |
Why?
| | Brain Diseases | 1 | 1998 | 141 | 0.140 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2017 | 60 | 0.140 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 642 | 0.140 |
Why?
| | Ultrasonography | 2 | 2019 | 716 | 0.140 |
Why?
| | Tissue Adhesives | 1 | 2016 | 18 | 0.140 |
Why?
| | Medical Marijuana | 1 | 2018 | 102 | 0.140 |
Why?
| | Contraception, Postcoital | 1 | 2016 | 6 | 0.140 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2015 | 30 | 0.140 |
Why?
| | Pregnancy, Unwanted | 1 | 2015 | 13 | 0.140 |
Why?
| | Cerebral Cortex | 1 | 1999 | 416 | 0.140 |
Why?
| | Internet | 2 | 2019 | 633 | 0.140 |
Why?
| | Anticoagulants | 1 | 2020 | 559 | 0.140 |
Why?
| | Patient Compliance | 2 | 2012 | 537 | 0.140 |
Why?
| | Risk Reduction Behavior | 2 | 2014 | 199 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2021 | 496 | 0.130 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 119 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 508 | 0.130 |
Why?
| | Placebos | 1 | 2015 | 202 | 0.130 |
Why?
| | Interpersonal Relations | 2 | 2017 | 345 | 0.130 |
Why?
| | Advanced Practice Nursing | 1 | 2015 | 20 | 0.130 |
Why?
| | Risk Factors | 10 | 2022 | 9003 | 0.130 |
Why?
| | Hot Flashes | 1 | 2015 | 72 | 0.130 |
Why?
| | Contraceptives, Oral | 1 | 2015 | 27 | 0.130 |
Why?
| | Curriculum | 3 | 2018 | 910 | 0.130 |
Why?
| | Papillomaviridae | 1 | 2015 | 101 | 0.130 |
Why?
| | Physician-Patient Relations | 2 | 2019 | 489 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2016 | 164 | 0.130 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2015 | 143 | 0.130 |
Why?
| | Pandemics | 1 | 2023 | 1355 | 0.130 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 161 | 0.130 |
Why?
| | Abdominal Abscess | 1 | 2014 | 27 | 0.120 |
Why?
| | Prediabetic State | 1 | 2017 | 234 | 0.120 |
Why?
| | Immunization Schedule | 1 | 2015 | 188 | 0.120 |
Why?
| | Neoplasm Grading | 3 | 2022 | 258 | 0.120 |
Why?
| | Glycoproteins | 1 | 2015 | 319 | 0.120 |
Why?
| | Fatigue | 1 | 2015 | 297 | 0.120 |
Why?
| | Endometrium | 1 | 2014 | 61 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 926 | 0.120 |
Why?
| | Digoxin | 1 | 2013 | 27 | 0.120 |
Why?
| | Peer Group | 1 | 2015 | 207 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 900 | 0.120 |
Why?
| | Otolaryngology | 1 | 2015 | 84 | 0.120 |
Why?
| | Schizophrenia | 4 | 2000 | 501 | 0.110 |
Why?
| | Logistic Models | 5 | 2019 | 1901 | 0.110 |
Why?
| | Brain | 8 | 2001 | 2490 | 0.110 |
Why?
| | Overweight | 1 | 2017 | 502 | 0.110 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2013 | 15 | 0.110 |
Why?
| | Motivational Interviewing | 1 | 2014 | 84 | 0.110 |
Why?
| | Pelvic Neoplasms | 1 | 2013 | 20 | 0.110 |
Why?
| | Antigens, CD | 1 | 2015 | 460 | 0.110 |
Why?
| | Robotics | 1 | 2014 | 83 | 0.110 |
Why?
| | Umbilical Cord | 1 | 2013 | 84 | 0.110 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2013 | 49 | 0.110 |
Why?
| | Exercise | 2 | 2021 | 1657 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 417 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2015 | 336 | 0.100 |
Why?
| | Rural Population | 3 | 2022 | 452 | 0.100 |
Why?
| | Hemorrhage | 1 | 2016 | 623 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2015 | 265 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 793 | 0.100 |
Why?
| | School Health Services | 1 | 2014 | 203 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2179 | 0.100 |
Why?
| | Guideline Adherence | 2 | 2021 | 523 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2015 | 399 | 0.100 |
Why?
| | Abortion Applicants | 1 | 2010 | 2 | 0.100 |
Why?
| | Glucose Tolerance Test | 2 | 2013 | 368 | 0.100 |
Why?
| | Odds Ratio | 2 | 2016 | 996 | 0.090 |
Why?
| | Domestic Violence | 1 | 2010 | 45 | 0.090 |
Why?
| | Blood Loss, Surgical | 3 | 2016 | 87 | 0.090 |
Why?
| | Sexual Partners | 2 | 2016 | 159 | 0.090 |
Why?
| | Anal Canal | 2 | 2022 | 83 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2017 | 524 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 556 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 394 | 0.090 |
Why?
| | Clinical Clerkship | 1 | 2011 | 98 | 0.090 |
Why?
| | Peptides | 1 | 2015 | 879 | 0.090 |
Why?
| | Sleep | 1 | 2015 | 660 | 0.090 |
Why?
| | Neoplasm Invasiveness | 3 | 2017 | 462 | 0.090 |
Why?
| | Referral and Consultation | 2 | 2018 | 648 | 0.090 |
Why?
| | Risk Assessment | 4 | 2016 | 3057 | 0.090 |
Why?
| | Preoperative Care | 3 | 2017 | 332 | 0.090 |
Why?
| | Latin America | 1 | 2009 | 74 | 0.090 |
Why?
| | Linear Models | 3 | 2019 | 827 | 0.090 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2009 | 19 | 0.090 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2020 | 49 | 0.090 |
Why?
| | Misoprostol | 1 | 2009 | 18 | 0.090 |
Why?
| | Research Design | 1 | 2015 | 969 | 0.090 |
Why?
| | Weight Loss | 2 | 2017 | 658 | 0.080 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.080 |
Why?
| | Case-Control Studies | 5 | 2020 | 3173 | 0.080 |
Why?
| | Interferon-beta | 2 | 2000 | 82 | 0.080 |
Why?
| | Medical Records Systems, Computerized | 1 | 2009 | 92 | 0.080 |
Why?
| | Sex Factors | 6 | 2020 | 1781 | 0.080 |
Why?
| | Dominance, Cerebral | 2 | 2000 | 53 | 0.080 |
Why?
| | Psychotic Disorders | 2 | 2000 | 135 | 0.080 |
Why?
| | Breast Feeding | 1 | 2012 | 386 | 0.080 |
Why?
| | Menarche | 1 | 2008 | 51 | 0.080 |
Why?
| | Pediatrics | 1 | 2016 | 985 | 0.080 |
Why?
| | Nausea | 2 | 2019 | 107 | 0.080 |
Why?
| | Temporal Lobe | 3 | 1997 | 90 | 0.080 |
Why?
| | Schizophrenia, Paranoid | 2 | 1997 | 10 | 0.080 |
Why?
| | Smoking | 1 | 2015 | 1487 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2012 | 556 | 0.080 |
Why?
| | Societies, Medical | 3 | 2018 | 703 | 0.080 |
Why?
| | Comorbidity | 2 | 2016 | 1527 | 0.070 |
Why?
| | Reference Values | 3 | 2018 | 775 | 0.070 |
Why?
| | Students, Health Occupations | 1 | 2007 | 23 | 0.070 |
Why?
| | Fathers | 1 | 2006 | 47 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2022 | 455 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2019 | 201 | 0.070 |
Why?
| | Prognosis | 4 | 2018 | 3443 | 0.070 |
Why?
| | Science | 1 | 2007 | 49 | 0.070 |
Why?
| | Clinical Laboratory Techniques | 1 | 2007 | 89 | 0.070 |
Why?
| | Length of Stay | 3 | 2015 | 1031 | 0.070 |
Why?
| | False Positive Reactions | 1 | 2006 | 115 | 0.070 |
Why?
| | Prevalence | 2 | 2017 | 2326 | 0.070 |
Why?
| | Auditory Cortex | 2 | 1997 | 41 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 1998 | 1965 | 0.070 |
Why?
| | Maternal Health Services | 1 | 2007 | 83 | 0.070 |
Why?
| | Azithromycin | 1 | 2006 | 81 | 0.070 |
Why?
| | Urethritis | 1 | 2005 | 2 | 0.070 |
Why?
| | Uterine Cervical Diseases | 1 | 2005 | 6 | 0.070 |
Why?
| | Self Efficacy | 2 | 2019 | 366 | 0.070 |
Why?
| | Fatty Liver | 1 | 2008 | 253 | 0.070 |
Why?
| | Teaching | 1 | 2007 | 236 | 0.060 |
Why?
| | Metformin | 1 | 2008 | 295 | 0.060 |
Why?
| | Biomarkers, Tumor | 2 | 2022 | 1059 | 0.060 |
Why?
| | Acanthosis Nigricans | 1 | 2003 | 6 | 0.060 |
Why?
| | Hospitals, University | 2 | 2016 | 172 | 0.060 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 394 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1167 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2008 | 1384 | 0.060 |
Why?
| | Urban Population | 2 | 2016 | 409 | 0.060 |
Why?
| | Cytochrome P-450 CYP3A Inducers | 1 | 2023 | 5 | 0.060 |
Why?
| | Ovulation | 1 | 2023 | 41 | 0.060 |
Why?
| | Program Evaluation | 2 | 2019 | 845 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2220 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2017 | 2513 | 0.050 |
Why?
| | Anxiety | 2 | 2019 | 846 | 0.050 |
Why?
| | Rifampin | 1 | 2023 | 69 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2179 | 0.050 |
Why?
| | Episiotomy | 1 | 2022 | 1 | 0.050 |
Why?
| | Anti-Bacterial Agents | 2 | 2014 | 1517 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 113 | 0.050 |
Why?
| | Pregnancy, Twin | 1 | 2021 | 22 | 0.050 |
Why?
| | Travel | 1 | 2022 | 116 | 0.050 |
Why?
| | Pharmacogenomic Variants | 1 | 2021 | 35 | 0.050 |
Why?
| | Biomedical Research | 1 | 2007 | 612 | 0.050 |
Why?
| | Alpha Rhythm | 1 | 2000 | 5 | 0.050 |
Why?
| | Reproduction | 1 | 2022 | 189 | 0.050 |
Why?
| | Wrist | 1 | 2021 | 51 | 0.050 |
Why?
| | Time-to-Pregnancy | 1 | 2020 | 3 | 0.050 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 2020 | 47 | 0.050 |
Why?
| | Mother-Child Relations | 1 | 2021 | 109 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1035 | 0.050 |
Why?
| | Coitus | 2 | 2011 | 28 | 0.050 |
Why?
| | Needs Assessment | 2 | 2015 | 327 | 0.050 |
Why?
| | Ethics, Medical | 1 | 2020 | 73 | 0.050 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2019 | 18 | 0.050 |
Why?
| | Analysis of Variance | 5 | 2005 | 1295 | 0.050 |
Why?
| | Refractory Period, Electrophysiological | 1 | 1999 | 5 | 0.050 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2019 | 21 | 0.050 |
Why?
| | Poverty | 2 | 2017 | 444 | 0.050 |
Why?
| | Electroencephalography | 2 | 1999 | 387 | 0.050 |
Why?
| | Tissue Donors | 1 | 2022 | 336 | 0.050 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 40 | 0.050 |
Why?
| | Mutation | 2 | 2022 | 3457 | 0.040 |
Why?
| | Reproducibility of Results | 3 | 2023 | 2874 | 0.040 |
Why?
| | Median Nerve | 1 | 1999 | 21 | 0.040 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 68 | 0.040 |
Why?
| | Ethics, Institutional | 1 | 2019 | 4 | 0.040 |
Why?
| | Visible Human Projects | 1 | 2019 | 3 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 23 | 0.040 |
Why?
| | Reproductive Health Services | 1 | 2019 | 7 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2000 | 160 | 0.040 |
Why?
| | Microsatellite Instability | 1 | 2019 | 31 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2019 | 28 | 0.040 |
Why?
| | DNA Polymerase II | 1 | 2019 | 29 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2000 | 207 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 351 | 0.040 |
Why?
| | Operative Time | 1 | 2019 | 114 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 80 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2018 | 70 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 23 | 0.040 |
Why?
| | Pituitary Gland | 1 | 1999 | 163 | 0.040 |
Why?
| | Midazolam | 1 | 2018 | 49 | 0.040 |
Why?
| | Morning Sickness | 1 | 2018 | 4 | 0.040 |
Why?
| | Electric Stimulation | 1 | 1999 | 268 | 0.040 |
Why?
| | Memory | 2 | 1999 | 230 | 0.040 |
Why?
| | Thalamus | 1 | 1999 | 80 | 0.040 |
Why?
| | Hippocampus | 2 | 2001 | 735 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1795 | 0.040 |
Why?
| | Patient Care | 1 | 2019 | 105 | 0.040 |
Why?
| | Psychology, Adolescent | 2 | 2008 | 63 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1346 | 0.040 |
Why?
| | Fentanyl | 1 | 2018 | 70 | 0.040 |
Why?
| | Memory, Short-Term | 1 | 2000 | 233 | 0.040 |
Why?
| | Carmustine | 1 | 1998 | 47 | 0.040 |
Why?
| | Frozen Sections | 1 | 2018 | 24 | 0.040 |
Why?
| | PTEN Phosphohydrolase | 1 | 2019 | 143 | 0.040 |
Why?
| | Creatine | 1 | 1998 | 56 | 0.040 |
Why?
| | Aspartic Acid | 1 | 1998 | 86 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 333 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2019 | 649 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 1998 | 222 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2019 | 208 | 0.040 |
Why?
| | Legislation, Drug | 1 | 2018 | 78 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 1974 | 0.040 |
Why?
| | Hysterosalpingography | 1 | 2017 | 6 | 0.040 |
Why?
| | Sterilization, Tubal | 1 | 2017 | 10 | 0.040 |
Why?
| | Transcription Factors | 1 | 2005 | 1570 | 0.040 |
Why?
| | Health Surveys | 1 | 2019 | 454 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1720 | 0.040 |
Why?
| | Survival Analysis | 1 | 2020 | 1267 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 1998 | 360 | 0.040 |
Why?
| | Health Facility Size | 1 | 2016 | 12 | 0.040 |
Why?
| | Hospitals, Private | 1 | 2016 | 12 | 0.040 |
Why?
| | Cisplatin | 1 | 1998 | 271 | 0.040 |
Why?
| | Marijuana Abuse | 1 | 2019 | 209 | 0.040 |
Why?
| | Pain Measurement | 1 | 2018 | 469 | 0.030 |
Why?
| | AC133 Antigen | 1 | 2015 | 20 | 0.030 |
Why?
| | Self Care | 1 | 2019 | 357 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 120 | 0.030 |
Why?
| | Terminal Care | 1 | 2019 | 187 | 0.030 |
Why?
| | Marriage | 1 | 2017 | 109 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2016 | 104 | 0.030 |
Why?
| | Medical Audit | 1 | 2016 | 75 | 0.030 |
Why?
| | Reaction Time | 4 | 2000 | 392 | 0.030 |
Why?
| | Patient Simulation | 1 | 2015 | 30 | 0.030 |
Why?
| | Stem Cell Transplantation | 1 | 2016 | 153 | 0.030 |
Why?
| | Brain Injuries | 1 | 2001 | 484 | 0.030 |
Why?
| | Radiotherapy | 1 | 2016 | 187 | 0.030 |
Why?
| | North America | 1 | 2016 | 266 | 0.030 |
Why?
| | Indians, North American | 1 | 2021 | 598 | 0.030 |
Why?
| | Ileus | 1 | 2015 | 10 | 0.030 |
Why?
| | Cell Count | 1 | 2015 | 315 | 0.030 |
Why?
| | Income | 1 | 2016 | 173 | 0.030 |
Why?
| | Urinary Retention | 1 | 2015 | 19 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 160 | 0.030 |
Why?
| | Competitive Behavior | 1 | 2015 | 40 | 0.030 |
Why?
| | Female Urogenital Diseases | 1 | 2014 | 5 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2006 | 525 | 0.030 |
Why?
| | Laparoscopy | 1 | 2019 | 418 | 0.030 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 25 | 0.030 |
Why?
| | Natural Family Planning Methods | 1 | 2014 | 2 | 0.030 |
Why?
| | Memory Disorders | 1 | 1996 | 168 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 296 | 0.030 |
Why?
| | Peritoneal Cavity | 1 | 2014 | 23 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 233 | 0.030 |
Why?
| | Receptors, Androgen | 1 | 2015 | 134 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 2015 | 132 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 151 | 0.030 |
Why?
| | Homosexuality, Male | 1 | 1995 | 166 | 0.030 |
Why?
| | Blood Volume | 1 | 2014 | 58 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2674 | 0.030 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 215 | 0.030 |
Why?
| | Pelvis | 1 | 2015 | 92 | 0.030 |
Why?
| | Insurance, Health | 1 | 2016 | 244 | 0.030 |
Why?
| | Disease Progression | 2 | 2017 | 2490 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 71 | 0.030 |
Why?
| | Hemostatics | 1 | 2014 | 50 | 0.030 |
Why?
| | Acoustic Stimulation | 3 | 2000 | 321 | 0.030 |
Why?
| | Cesarean Section | 1 | 2015 | 165 | 0.030 |
Why?
| | Drainage | 1 | 2014 | 158 | 0.030 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 21 | 0.030 |
Why?
| | Educational Measurement | 1 | 2016 | 289 | 0.030 |
Why?
| | Child Development | 1 | 1998 | 410 | 0.030 |
Why?
| | Insulin | 1 | 2003 | 2170 | 0.030 |
Why?
| | Receptors, Progesterone | 1 | 2015 | 325 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1474 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1998 | 1947 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2015 | 736 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2062 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 387 | 0.030 |
Why?
| | Alcoholism | 1 | 1999 | 717 | 0.030 |
Why?
| | Patient Readmission | 1 | 2018 | 633 | 0.030 |
Why?
| | Multiple Sclerosis | 1 | 1998 | 384 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2019 | 1056 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3590 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 1998 | 540 | 0.030 |
Why?
| | Perception | 1 | 2015 | 314 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2014 | 546 | 0.030 |
Why?
| | Text Messaging | 1 | 2014 | 155 | 0.030 |
Why?
| | Escherichia coli | 1 | 2016 | 758 | 0.030 |
Why?
| | Specialty Boards | 1 | 2011 | 39 | 0.030 |
Why?
| | Registries | 1 | 2019 | 1810 | 0.020 |
Why?
| | Phenotype | 1 | 1999 | 3004 | 0.020 |
Why?
| | Faculty | 1 | 2011 | 135 | 0.020 |
Why?
| | Medicaid | 1 | 2014 | 411 | 0.020 |
Why?
| | Students | 1 | 2014 | 509 | 0.020 |
Why?
| | Interferon beta-1a | 2 | 2000 | 12 | 0.020 |
Why?
| | Physicians | 1 | 2018 | 794 | 0.020 |
Why?
| | New York City | 1 | 2009 | 75 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 2369 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1637 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2011 | 599 | 0.020 |
Why?
| | Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 2000 | 116 | 0.020 |
Why?
| | Gravidity | 1 | 2008 | 8 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 794 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2851 | 0.020 |
Why?
| | Southwestern United States | 1 | 2008 | 94 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 81 | 0.020 |
Why?
| | Aging | 1 | 1998 | 1677 | 0.020 |
Why?
| | Quality Improvement | 1 | 2015 | 963 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9493 | 0.020 |
Why?
| | Hospitalization | 1 | 2016 | 1785 | 0.020 |
Why?
| | Urine | 1 | 2007 | 59 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 199 | 0.020 |
Why?
| | Social Perception | 1 | 2008 | 98 | 0.020 |
Why?
| | Puberty | 1 | 2008 | 144 | 0.020 |
Why?
| | Medical Indigency | 1 | 2006 | 10 | 0.020 |
Why?
| | Urinalysis | 1 | 2007 | 68 | 0.020 |
Why?
| | Diet | 1 | 2014 | 1155 | 0.020 |
Why?
| | Forecasting | 1 | 2008 | 354 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2007 | 115 | 0.020 |
Why?
| | Education | 1 | 2007 | 105 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 254 | 0.020 |
Why?
| | Social Environment | 1 | 2008 | 294 | 0.020 |
Why?
| | Research Support as Topic | 1 | 2007 | 114 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2484 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 521 | 0.020 |
Why?
| | Universities | 1 | 2007 | 347 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2436 | 0.020 |
Why?
| | Attention | 2 | 1999 | 408 | 0.020 |
Why?
| | Sex Characteristics | 2 | 1999 | 671 | 0.020 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2004 | 42 | 0.010 |
Why?
| | Self Concept | 1 | 2005 | 215 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 336 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2005 | 1125 | 0.010 |
Why?
| | Research | 1 | 2005 | 411 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1997 | 710 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1664 | 0.010 |
Why?
| | Electromagnetic Fields | 1 | 1999 | 21 | 0.010 |
Why?
| | Schizophrenic Psychology | 1 | 1999 | 113 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 1946 | 0.010 |
Why?
| | Wechsler Scales | 1 | 1998 | 57 | 0.010 |
Why?
| | Cognition | 1 | 2005 | 1025 | 0.010 |
Why?
| | Gadolinium | 1 | 1998 | 79 | 0.010 |
Why?
| | Sound Localization | 1 | 1998 | 64 | 0.010 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 1999 | 220 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 1995 | 73 | 0.010 |
Why?
| | Verbal Behavior | 1 | 1995 | 48 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1999 | 521 | 0.010 |
Why?
| | Confidence Intervals | 1 | 1996 | 324 | 0.010 |
Why?
| | Space Perception | 1 | 1995 | 65 | 0.010 |
Why?
| | Recurrence | 1 | 1998 | 975 | 0.010 |
Why?
| | Software | 1 | 1999 | 613 | 0.010 |
Why?
| | Cognition Disorders | 1 | 1999 | 529 | 0.010 |
Why?
|
|
Sheeder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|